Few people realise that the Emergency Use Authorisation (EUA) of the Pfizer-BioNTech Covid-19 Vaccine/BNT162b2 was granted on the efficacy data of 170 patients. The 162 who received a placebo and 8 patients who were vaccinated formed the basis of the 95 per cent efficacy claims. There has not been much […]
Report 39: Despite Incomplete Safety Trials, the Food and Drug Administration (FDA) Grants Full Approval to Pfizer-BioNTech’s COMIRNATY® for Adolescents 12-15 Years of Age
Without a completed safety study or expert committee review, the FDA issued a supplemental Biologics License Application (“sBLA”) approval letter granting full FDA approval to Pfizer-BioNTech’s COMIRNATY® COVID-19 mRNA vaccine for use in children ages 12-15. This was done even though safety study completion, on which approval should be based, […]
New Fears For Vaccinated Pregnant Mothers
What was the basis for Pfizer and the FDA to declare the MRNA vaccine ‘safe and effective’ for pregnant and breastfeeding women? Just 44 French rats — in a study run by shareholders and employees of Pfizer and BioNTech. Now it’s clear there have been shockingly serious adverse reactions, including […]
Report 14: Were We Lied to by the FDA?
What’s the difference between Pfizer’s FDA approved COMIRNATY and the emergency use authorized “vaccine?” Only the law, not science, says the FDA. Were we lied to by the U.S. Food and Drug Administration (FDA) and the media when they told us that, if we received the Pfizer “vaccine” after […]
Report 03: Phase 1 /2 Study of COVID-19 RNA Vaccine BNT162b1 in Adults: Key Processes Missing.
Mulligan, Lyke et al. Nature Published online August 12, 2020. Cite this article as: Mulligan, M. J. et al. Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature https://doi.org/10.1038/s41586-020-2639-4 (2020). P1 p2: The authors’ put forth the argument that mRNA in BNT162b1 (Note this series used BNT162b1 […]